Role of Chemopreventive Agents in Women at Increased Risk for Breast Cancer

Cancer Network spoke with Charles Shapiro, MD, about the USPSTF's stance on use of tamoxifen, raloxifene, and aromatase inhibitors to prevent breast cancer.